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Abstract
 
The factors regulating germinal center (GC) B cell fate are poorly understood. Recent studies
have defined a crucial role for the B cell–activating factor belonging to TNF family (BAFF; also
called BLyS) in promoting primary B cell survival and development. A role for this cytokine in
antigen-driven B cell responses has been suggested but current data in this regard are limited. A
BAFF receptor expressed by B cells (BAFF-R/BR3) is defective in A/WySnJ mice which ex-
hibit a phenotype similar to BAFF-deficient (BAFF
 
 
 
/
 
 
 
) animals. Here, we show that although
GC responses can be efficiently induced in both A/WySnJ and BAFF
 
 
 
/
 
 
 
 mice, these responses
 
are not sustained. In BAFF
 
 
 
/
 
 
 
 mice, this response is rapidly attenuated and accompanied by per-
turbed follicular dendritic cell development and immune complex trapping. In contrast, analysis
of the A/WySnJ GC response revealed a B cell autonomous proliferative defect associated with
reduced or undetectable Ki67 nuclear proliferation antigen expression by GC B cells at all
stages of the response. These data demonstrate a multifaceted role for the BAFF pathway in
regulating GC progression.
Key words: B cell development • germinal center response • B cell memory • 
immunodeﬁciency • FDC reticulum
 
Introduction
 
T cell–dependent (TD) antigens induce germinal centers
(GC) in the follicles of secondary lymphoid organs (1). In
GCs, B cells undergo rapid proliferation and Ig V region
somatic hypermutation (1–3). B cell mutants with high affinity
for antigen are positively selected into the Ab-forming cell
or memory compartments (4–6). B cell mutants with low
affinity for antigen and apparently B cells with autoreactivity
are negatively selected (7, 8). Despite these insights into the
pivotal function of GCs in TD B cell responses and peripheral
tolerance, the factors that regulate GC B cell survival and
selection are still poorly understood.
The cytokine B cell–activating factor belonging to TNF
family (BAFF; also called TALL-1, THANK, BLyS, and
zTNF4) is a member of the TNF ligand family (9–13).
BAFF is predominantly expressed by myeloid cells, including
monocytes and DCs (9–12). Of the three known recep-
tors, BCMA (13, 14), TACI (15, 16), and BAFF receptor
(BAFF-R) (BR3) (17, 18) expressed on B cells that can
bind this cytokine, BAFF-R appears to be specific for
BAFF since it does not bind the related cytokine APRIL
(17, 18). Studies on BAFF-deficient (BAFF
 
 
 
/
 
 
 
) mice have
defined a crucial role for BAFF in primary B cell survival
and development (19, 20). Such mice display a loss of tran-
sitional type 2 (T2), follicular (B2), and marginal zone B
cells. However, BM B lymphopoiesis, transitional type
(T1) B cells, B1 cells, and other hematopoietic cell lineages
appear unaffected.
Analysis of BAFF transgenic mice revealed expanded B
cell numbers in all peripheral B cell compartments (21).
BAFF was also shown to augment B cell proliferation induced
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Abbreviations used in this paper:
 
 BAFF, B cell–activating factor belonging to
TNF family; BAFF-R, BAFF receptor; BrdU, bromodeoxyuridine;
Bcmd, B cell maturation defect; Bcl-6, B cell lymphoma-6; FDC, follicular
DC; GC, germinal center; LT, lymphotoxin; TUNEL, terminal deoxy-
nucleotidyl transferase nick end labeling; HRP, horseradish peroxidase;
IC, immune complex; PI, propidium iodine; PNA, peanut agglutinin;
T1, transitional type 1; T2, transitional type 2; TD, T cell–dependent.T
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by anti-IgM antibody in vitro (9, 10). In addition, BAFF
promotes increased survival of mature resting B cells in
vitro (21, 22). These data indicate a role for BAFF beyond
the T1-T2 transition.
The phenotype of A/WySnJ mice closely resembles that
of BAFF
 
 
 
/
 
 
 
 mice in exhibiting an 
 
 
 
10-fold loss of splenic B
cells, including T2, B2, and marginal zone B cells (23–25).
As in BAFF
 
 
 
/
 
 
 
 mice, BM B lymphopoiesis, T1 transitional
B cells, B1 cells, and other hematopoietic lineages appear
unaffected (25). The B cell maturation defect (
 
Bcmd
 
)
 
 
 
locus
(26) was shown to contribute to this peripheral B cell defect
(23, 24). The BAFF-R gene was localized to the 
 
Bcmd
 
 locus
(17, 18). Expression of a defective BAFF-R, resulting from
the mutation of the cytoplasmic domain was reported in
A/WySnJ mice (15, 17). These data strongly indicate that
the mutated BAFF-R is encoded by the 
 
Bcmd
 
 locus.
Despite their B lymphopenia, BAFF
 
 
 
/
 
 
 
 and A/WySnJ
mice do contain splenic B2-like cells based on locale and cell
surface phenotype (19, 24), indicating that the T1-T2 block is
not absolute. Moreover, A/WySnJ and mice in which BAFF
function is inhibited can mount high affinity class switched se-
rum antibody responses to TD antigens, albeit at levels lower
than normal mice (15, 18, 27). Therefore, we speculated that
a GC response could be induced in these mice, allowing as-
sessment of the role the BAFF–BAFF-R pathway might play
in this response. Our results suggest that GCs can be effi-
ciently formed in these mice. However, in both A/WySnJ
and BAFF
 
 
 
/
 
 
 
 mice, GC responses are not sustained. There-
fore, our data demonstrate a novel role for the BAFF pathway
in the regulation of antigen-driven B cell differentiation.
 
Materials and Methods
 
Mice and Immunizations.
 
A/J, A/WySnJ, 
 
 
 
MT (on a C57BL/
6J background), (A/J 
 
 
 
 C57BL/6J) F1 (AB6F1/J), and C57BL/6
mice were purchased from The Jackson Laboratory and were
maintained in a pathogen-free facility. BAFF
 
 
 
/
 
 
 
 mice were gen-
erated (19) and maintained in a pathogen-free facility, and all ani-
mal protocols were approved by the Institutional Animal Care
and Use Committee. All mice (9–12 wk) were immunized i.p.
with SRBC (Lampire Biological Labs) as described (28, 29).
 
Antibodies.
 
The following antibodies and other reagents were
used: FITC-GL7; PE–anti–TCR-
 
 
 
; PE–anti–Fc
 
 
 
RII/Fc
 
 
 
RIII
(clone 2.4G2); PE and PerCP–anti-B220 (clone RA3–6B2);
FITC–anti-IgD (clone 11–26c.2a); APC–anti–mouse IgM (clone
II/41); biotin–anti-CD35 (clone 8C12); rat IgM anti–mouse GL7;
rat IgG antibody to mouse follicular DCs (FDC-M1); streptavi-
din-CyChrome (BD Biosciences); rabbit polyclonal antibody to
Bcl-6/N-3 (Santa Cruz Biotechnology, Inc.); alkaline-phosphatase
and biotin-(Fab
 
 
 
)
 
2
 
 mouse anti–rat IgG; HRP donkey anti–mouse
IgM and biotin donkey anti–rabbit IgG (Jackson Immunoresearch
Laboratories); HRP-peanut-agglutinin (PNA) (Sigma-Aldrich);
biotin-LS136 (anti-
 
 
 
1mAb); HRP–anti-CD4 (clone GK1.5; made
in house); anti-Ki67 (clone TEC-3) and streptavidin-alkaline
phosphatase (Dako); biotin–anti-B220 (clone RA3–6B2), biotin–
anti-IgD (clone 11–26; Southern Biotechnology Associates, Inc.),
and streptavidin-PE (Molecular Probes).
 
Immunohistology.
 
Spleen cryostat sections (5–6 
 
 
 
m) were pre-
pared as previously described (30). Immunohistology was per-
formed using either visible dye staining as described (30), except
 
the Abs were detected using the Vector Blue Alkaline-phos-
phatase Substrate kit III and the Vector NovaRed kit for peroxi-
dase (Vector Laboratories) or immunofluorescent staining as de-
scribed (29). The stained sections were analyzed using light or
fluorescence microscopy (Leitz Diaplan; Axioplan Universal Mi-
croscope; Carl Zeiss MicroImaging, Inc.), and digital images were
captured using either an Eastman Kodak Co. camera or an axiocam
using the Openlab software.
 
Cell Cycle Analysis by Flow Cytometry.
 
Cell suspensions pre-
pared from spleens on day 8 post SRBC immunization were
RBC depleted using ACT buffer and stained with GL7-FITC,
anti-B220–PE and biotin–anti-IgD followed by streptavidin-
CyChrome. B220
 
 
 
 IgD
 
 
 
 GL7
 
 
 
 GC and B220
 
 
 
 IgD
 
 
 
 GL7
 
 
 
B
cells were separated on a Coulter Epics Elite flow cytometric cell
sorter, and propidium iodine (PI) staining was performed on the
sorted cells as described (31). PI staining was analyzed using a
Coulter Epics XL/MCL analyzer. The data were analyzed using
FlowJo software (Treestar).
 
Microdissection of GCs, PCR, Cloning, and Sequencing.
 
Spleen
sections were stained with PNA and LS136 (anti-
 
 
 
1
 
 mAb). PNA
 
 
 
 
 
1
 
 
 
 and PNA
 
 
 
 
 
 
 
1
 
 
 
 GC B cells were microdissected and processed as
described (32). V
 
 
 
1
 
 and V
 
H
 
186.2 (J558 family) genes were amplified
as described (33, 34). V
 
 
 
 genes were amplified using a degenerate
universal 5
 
 
 
 primer (35). The kappa 3
 
 
 
 primer (AATCATTC-
CAATCTCTGGTGG) and 3
 
 
 
 nested primer (CAATCTCTG-
GTGGGACAGT) hybridize in a region 5
 
 
 
of J
 
 
 
3 in the intronic se-
quence. PCR product purification, cloning, sequencing, and somatic
mutation analyses were done as described (34).
 
Terminal Deoxy-nucleotidyl Transferase Nick End Labeling
 
 
 
Assay.
 
Spleen sections were first stained with GL7 as described (30).
A terminal deoxy-nucleotidyl transferase nick end labeling
(TUNEL) assay was then performed on the same spleen sections
using an ApopTag in situ apoptosis detection kit (Intergen). Alka-
line-phosphatase and HRP-labeled antibodies were visualized as
described above. GCs were then categorized into small, medium,
and large sizes as described (36). Apoptotic activity was assessed
by counting the number of TUNEL-positive nuclei in small and
medium GCs.
 
In Situ Bromodeoxyuridine Proliferation Assay.
 
An in situ bro-
modeoxyuridine (BrdU) proliferation assay was performed using
a kit (Roche). Mice were immunized with SRBC as above. At
different time points (day 6, 9, and 14) postimmunization, BrdU
was administered i.p. 1 h before sacrificing and freezing spleens.
One of two adjacent spleen sections (5–6 
 
 
 
m) at each time point
were stained with anti-IgD and PNA, and alkaline-phosphatase
(IgD) and HRP-labeled (PNA) antibodies were revealed as de-
scribed above. BrdU uptake was detected on the other section,
after the first two staining procedures had been completed as de-
scribed (37), using mouse anti-BrdU followed by alkaline phos-
phatase conjugated anti–mouse Ig.
 
In Vitro Stimulation and Intracellular Staining of B Cells for
Ki67. 
 
Small dense splenic B cells were isolated and stimulated
with antimurine CD40 (FGK45, a gift from Dr. Anton Rolink,
Department of Immunology, University of Basel, Basel, Switzer-
land) and recombinant murine IL-4 (Pepro Tech) as previously
described (36). Resting (0 h) and stimulated (48 h) B cells were
cytospun (450 rpm, 10 min) onto charged slides and stained for
Ki67 as described above. Fixing and permeabilization were done
using a kit from Caltag Laboratories.
 
Passive Immune Complex Deposition Assay. 
 
Mice were immu-
nized with SRBC as above. On day 8 postimmunization, the mice
were injected with either rabbit anti-HRP serum or normal rabbit
serum followed by HRP 1 d later as described (30). 1 d after that,T
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the mice were killed, and spleens were frozen and sectioned. HRP
activity was visualized via fluorescent staining with goat anti-HRP
(Sigma-Aldrich) followed by biotin-donkey anti–goat (Jackson
ImmunoResearch Laboratories) and SA-488 (Molecular Probes).
 
Mixed BM Chimeras.
 
Mixed BM chimeras were created
through adoptive transfer of a 1:1 mixture of BM from A/J and
 
 
 
MT (C57BL/6–Igh-6
 
tm1Cgn
 
) or A/WySnJ and 
 
 
 
MT mice into
(A/J 
 
  
 
C57BL/6J) F1 mice, designated AB6F1. AB6F1 mice
were given 1,000 rad whole body irradiation before the injection
in the lateral tail vein of 
 
 
 
6 
 
 
 
 10
 
6
 
 RBC and T-depleted BM
cells. Chimeric mice were allowed to reconstitute for 35 d before
immunization with SRBC as above. Mice were killed at different
time points (day 6, 9, and 14) postimmunization, and spleens
were frozen as described above. Immunohistology was performed
on spleen sections of these mice, also as described above.
 
Results
 
A/WySnJ and BAFF
 
 
 
/
 
 
 
 Mice Have Reduced but Similar
Numbers of IgM
 
low
 
, IgD
 
high
 
 B Cells Located in Splenic Follicular
Areas.
 
Previous studies have suggested that the block in
mature B cell development may be more severe in BAFF-
 
deficient than in A/WySnJ mice (18–20). Therefore, we
compared B cell phenotype and locale in the spleens of
these mice. Immunohistology analysis revealed that al-
though the follicular areas in both strains are clearly smaller
than in control mice, they appear reduced to similar extents
(Fig. 1 A). B cells of both strains in these areas stain strongly
with anti-IgD and weakly with anti-IgM. Quantitative
flow cytometric analysis showed that both strains have re-
duced but similar numbers of sIgM
 
low
 
 and sIgD
 
high
 
 splenic
B cells (Fig. 1 B).
 
GC Kinetics in A/WySnJ and BAFF
 
 
 
/
 
 
 
Mice.
 
The in-
duction of robust GC responses in mice immunized with
SRBCs has been shown previously (28, 29). A/WySnJ and
A/J control and BAFF
 
 
 
/
 
 
 
 and C57BL/6 mice were immu-
nized with SRBC. Spleen sections obtained at multiple
time points were stained with PNA or GL7. Defects in the
GC response can be manifested by changes in GC size, fre-
quency, and kinetics (34, 36, 38). Therefore, GCs were
counted and categorized as small, medium, and large at all
time points as described (36). The total number of GCs at
day 6 of the response in all four groups was comparable
Figure 1. B cell areas and phenotype in the spleens of BAFF /  and A/WySnJ mice. Spleens of unimmunized BAFF / , C57BL/6, A/WySnJ, and A/J
mice were processed for histology and flow cytometry and stained with the indicated reagents. Representative splenic areas in adjacent sections (A) and
flow cytometric plots (B) are illustrated for each strain. Due to strain differences in average levels of sIgD revealed in the A/J and C57BL/6 samples, the
gates used to define the sIgMlow sIgDhigh subpopulation in A/WySnJ and BAFF /  were set at different positions. Flow cytometry data were obtained
from the pooled spleens of two mice of each genotype.T
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(Fig. 2). However, the kinetics and magnitude of GC pro-
gression differed. In A/WySnJ spleens, there were very few
large GCs at any time point, small GCs dominated the re-
sponse at day 6, and total GC numbers decreased rapidly
after day 12 (Fig. 2 A). In contrast, the number and size of
GCs at day 6 appeared normal in BAFF
 
 
 
/
 
 
 
 spleens, but
there was a dramatic decrease in total GC numbers after
day 6, only small GCs were prevalent at day 9, and GCs
were nearly absent at day 12 (Fig. 2 B).
 
GC Substructure in A/WySnJ and BAFF
 
 
 
/
 
 
 
 Mice.
 
Spleen sections from the SRBC response were stained with
GL7 in combination with a variety of antibodies to define
GC substructure. A/J and A/WySnJ GCs from all time
points where GCs were observed revealed characteristic
“sectoring” due to up-regulated FDC-M1 and Fc
 
 
 
RIIB
(2.4G2) levels on the FDC reticulum present in a large re-
gion of each GC and low to undetectable levels of expres-
sion of these markers on GC B cells where the FDC net-
work was absent (29). Representative images from day 12
are shown in Fig. 3 A, left panels. In contrast, day 6 BAFF
 
 
 
/
 
 
 
GCs revealed abnormal staining with FDC-M1 and 2.4G2
(Fig. 3 A, right). This staining was far less extensive, less in-
 
tense, and more punctate than what is characteristic of nor-
mal GCs. However, the primary FDC reticulum appeared
normal in both BAFF
 
 
 
/
 
 
 
 and A/WySnJ GCs as indicated by
intensity and distribution of anti-CD35 staining (Fig. 3 B).
T cell migration to the GC was investigated by staining
spleen sections with GL7 and anti–TCRC-
 
 
 
. T cell num-
bers and locale in the GCs of A/WySnJ (day 12) and
BAFF
 
 
 
/
 
 
 
 (day 6) mice were comparable to controls (Fig. 3
C). We also examined the expression of the transcription
factor Bcl-6, which has been shown to be highly and spe-
cifically expressed in GC B cells (39, 40). Bcl-6
 
 
 
/
 
 
 
 mice
have impaired GC formation (41). Fig. 3 D shows that Bcl-6
expression in A/WySnJ (day 12) and BAFF
 
 
 
/
 
 
 
 (day 6) GCs
was comparable to controls. Analysis of T cell locale and
number and Bcl-6 expression at other time points gave re-
sults similar to those illustrated in Fig. 3, C and D.
 
Immune Complex Deposition in BAFF
 
 
 
/
 
 
 
 and A/WySnJ
GCs.
 
These data showed that although GC substructure
is apparently normal in BAFF-R–defective A/WySnJ
mice, development of a mature FDC reticulum does not
take place in the GCs of BAFF
 
 
 
/
 
 
 
 mice. Although the pre-
cise role of FDCs in the GC response remains controver-
sial, their ability to trap and retain native antigen in the
form of immune complexes (ICs) is thought to be impor-
tant for stimulation of GC B cell proliferation and differen-
tiation (42–45).
Passive splenic IC deposition assays were performed on
BAFF
 
 
 
/  and A/WySnJ mice undergoing immune re-
sponses to SRBC. These did not reveal any major differ-
ences in IC amounts or locale in A/WySnJ and A/J splenic
GCs (Fig. 4, right). In contrast, little IC deposition could
be detected on FDCs in the GCs of BAFF /  mice (Fig. 4,
left). Thus, the attenuation of the GC response in these
mice may result from a lack of sufficient antigen trapping in
GCs, secondary to pleiotropic perturbations in FDC devel-
opment (see Discussion). In contrast, clues to the mecha-
nism(s) responsible for attenuation of the GC response in
A/WySnJ mice were not provided by these studies, neces-
sitating further analysis of this response.
Apoptosis in GCs of A/WySnJ Mice. To investigate
whether the decline of GC numbers in A/WySnJ mice was
correlated with increased intra-GC apoptosis, TUNEL as-
says were done on spleen sections. Due to the low fre-
quency of large GCs in A/WySnJ mice, small and medium
GCs were considered for this analysis. Although the aver-
age number of apoptotic nuclei per GC at all time points
was slightly higher in A/WySnJ mice compared with A/J
control mice (Fig. 5), the differences were not statistically
significant (Student’s t test at 90% confidence).
Proliferation in the Very Early Stages of the GC B Cell Re-
sponse in A/WySnJ Mice Appears Normal. GC B cell pro-
liferation in A/WySnJ mice was evaluated using an in situ
BrdU incorporation assay. As shown in Fig. 6 A, BrdU-
positive cells (reddish-brown, bottom panels, day 9 and 14)
reflect proliferating B cells in a PNA  IgD  GC (red-
orange, top panels) revealed in the adjacent section. GC
cell BrdU staining frequency and intensity on day 9 were
Figure 2. Kinetics of germinal center (GC) induction. (A) A/J ( ) and
A/WySnJ ( ) mice and (B) BAFF /  (  ) and C57BL/6 mice ( ,
BAFF / ) were immunized with SRBC. Two spleen sections per mouse
obtained at each time point, each at least 40–50 sections apart, were subjected
to immunohistological analysis. Small, medium, and large PNA  GCs
were counted per 10  field. The data represent at least three mice from
each group at each time point.T
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comparable in A/J and A/WySnJ mice. In contrast, very
few intensely staining BrdU  cells were seen in day 14
A/WySnJ GCs.
Since levels of DNA damage are elevated in GC B cells
(46), much of the BrdU incorporation could have resulted
from DNA synthesis due to repair and not chromosomal
Figure 3. Immunofluorescent staining of B cells, FDCs, and T cells in GCs. Data from day 12 of the SRBC response in A/J and A/WySnJ mice and
those from day 6 in BAFF /  and C57BL/6 are shown. Staining was performed (A) with mAbs against GL7 (green) and FDC-M1 and 2.4G2 (both in
red), (B) with GL7 (green) and CD35 (CR1) in red, (C) with anti–TCR-C   (red) and GL7 (green), and (D) with polyclonal antiserum against Bcl-6
(red). The data are representative of three mice from each group. Original magnification of images was 25 .T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
BAFF and BAFF-R Regulate Germinal Center Progression 1162
replication. For this reason, GC B cell proliferative status
was investigated by PI cell cycle analysis on GC B cells ob-
tained by FACS® on day 8 post-SRBC immunization (Fig.
6 B). The percentage of B220  IgD  GL7  B cells (de-
fined as GC B cells, bottom panels) that were in S/G2-M
phases in A/WySnJ mice was comparable to that in A/J
mice. Together, the BrdU and PI data suggest that GC B
cells in A/WySnJ mice are proliferating normally during
the early but not the intermediate stages of this response. Due
to the diminution of GC number and size in A/WySnJ
mice, it was technically impossible to perform the PI analy-
sis at later time points.
Reduced Ki67 Expression in A/WySnJ GCs. To further
evaluate the proliferative status of B cells in A/WySnJ and
BAFF /  GCs we examined the expression of Ki67 (a nu-
clear proliferation antigen). As illustrated in Fig. 7 A, we
categorized GCs as ( / ), most GC B cells positive for
Ki67 staining, ( / ), 10–60% of GC B cells positive
for Ki67 staining, and ( / ), 0–9% of GC B cells positive
for Ki67 staining.
Analysis of BAFF /  mice revealed that GL7  GC cells
were uniformly Ki67 /  at all time points, even in the
small GCs prevalent at day 9 and the rare GCs present at
day 12 (Fig. 7 B). In striking contrast, on day 6 58% of
A/WySnJ GCs had reduced or undetectable ( / ) levels
of Ki67 expression. On day 9,  70% of GCs in these mice
was moderately positive ( / ). However, on day 12
 90% of A/WySnJ GCs had dramatically reduced or un-
detectable ( / ) levels of Ki67 expression. A/J mice ex-
hibited bright and extensive (Fig. 7, B and C,  / ) Ki67
nuclear staining in activated B cells scattered in white and
red pulp areas as early as day 3 (not depicted) and in all GCs
at all other time points.
To evaluate whether A/WySnJ B cells have a generic
defect in ability to express high levels of the Ki67 antigen,
we stimulated purified splenic B cells from A/J and
A/WySnJ mice with anti-CD40 and IL-4 in vitro and as-
sayed expression of Ki67. Fig. 7 D illustrates that the major-
ity of B cells from both strains became strongly Ki67 positive
after 48 h of stimulation. The slight reduction in Ki67-posi-
tive cells observed in A/WySnJ cultures was not significant
and may have resulted from higher levels of non–B cell con-
tamination due to the B lymphopenia of these mice.
The GC Defect in the A/WySnJ Mice Is B Cell Autono-
mous. To determine whether the attenuated GC response
of A/WySnJ mice was due to a B cell defect, we generated
mixed BM chimeras of A/J    MT (B cell deficient) mar-
row  → AB6F1, and A/WySnJ     MT marrow →
AB6F1. Thus, either A/J (Bcmd ) or A/WySnJ (Bcmd ) B
cell compartments were reconstituted in the presence of
chimeric accessory cell compartments (Fig. 8 A). As shown
Figure 5. Quantitation of apoptotic nuclei in GCs at multiple time
points. Eight randomly chosen small and medium GCs from two to three
A/J ( ) and A/WySnJ ( ) mice at each time point of the SRBC response
were assessed for apoptotic activity by enumerating TUNEL-positive nuclei.
Horizontal bars represent mean values.
Figure 4. Immune complex trapping in A/WySnJ and BAFF /  GCs. A/WySnJ, A/J, BAFF / , and C57BL/6 mice were immunized with SRBC
and subsequently injected with HRP and anti-HRP to evaluate IC trapping as described in Materials and Methods. The figure illustrates representative
splenic areas in adjacent sections stained either with anti-CD35 to reveal the follicular reticulum or with an anti-HRP antibody. Original magnification
of images was 10 . Arrows indicate areas of IC deposition on the follicular reticulum.T
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in Fig. 8 B, FDC “maturation” and “sectoring” in these
chimeric mice on day 9 post-SRBC immunization were
comparable to that observed in A/J and A/WySnJ mice,
respectively (Fig. 3 A). Ki67 expression, or lack thereof,
(Fig. 8 C) and T cell numbers and locale (Fig. 8 D) in GCs
of chimeric mice were also comparable to those in their
nonchimeric counterparts. The kinetics of the GC response
was also comparable (not depicted) to those in A/J and
A/WySnJ mice (Fig. 2). These data indicate that the defect
in the A/WySnJ GC response is B cell autonomous and not
caused by perturbed microenvironments or accessory cells.
Precursors of the GC B Cell Response in A/WySnJ Mice Ap-
pear Not To Be B1 Cells. The development of B1 cells is
normal in both A/WySnJ and BAFF /  mice (19, 25).
Therefore, we investigated whether the precursors of GC
B cells in A/WySnJ mice could be B1 cells. These cells
have been shown to express VH genes with either no or
only short stretches of N sequence additions at V-D-J junc-
tions (47, 48). We analyzed the N-sequence diversity at
V-D-J junctions (Table I) of the VDJ rearrangements of VH
genes recovered by microdissection and PCR amplification
of A/WySnJ SRBC-induced GCs. The N regions were
comparable in length (7–18 nucleotides) and nucleotide
composition (55% G   C) to those in A/J GCs (5–20 nu-
cleotides and 60% G   C).
Somatic Hypermutation in A/WySnJ GCs. Since so-
matic hypermutation generates the V region substrates for
antibody affinity maturation, a process that takes place in
GCs (1–7), perturbations in hypermutation in A/WySnJ
GCs might contribute to GC diminution. In normal mice,
the hypermutation process is activated after GC formation,
and a high frequency of V region mutation becomes evi-
dent during the intermediate and latter stages of the re-
sponse (49, 50). A/J and A/WySnJ mice were immunized
with SRBCs, and PNA   1
  splenic GC B cells were mi-
crodissected for genomic DNA amplifications and sequenc-
ing of V 1 and VH genes, and PNA   1
  splenic GC B
cells microdissected for recovery of V  and VH genes. The
mutation frequencies in day 9 (intermediate) and day 16
(late) A/WySnJ GCs were comparable to those in A/J mice
(Table II). Moreover, the chemical nature and distribution
of mutations in V region genes obtained from A/WySnJ
GCs were also comparable to those from A/J mice (unpub-
lished data).
Discussion
Previous findings on the influence of BAFF on B cell
behavior led to speculation that this cytokine might play a
role in the antigen-driven stages of B cell development (9,
10, 13, 21, 22). In testing this hypothesis, we found that
GCs can efficiently form in BAFF /  and in BAFF-R–
defective A/WySnJ mice. However, the GC response is not
sustained in either strain, and our data strongly suggest that
the mechanisms by which GC integrity is compromised
differ. Therefore, although BAFF is dispensable for the
initiation of the GC response, signaling via this pathway
Figure 6. (A) In situ BrdU incorporation assay in A/J and A/WySnJ
GCs. One of two parallel sections obtained from SRBC-immunized mice
was stained (top panel, for day 9 and 14) with anti-IgD (blue) and PNA
(red), and the other section (bottom panel, for day 9 and day 14) was
stained with anti-BrdU (red). Data are representative of three mice at each
time point. (B) PI cell cycle analysis on GC B cells (B220 GL7 IgD )
obtained by FACS® on day 8 post-SRBC immunization. The horizontal
bar and number in each panel represent GC B cells that are in S/G2-M
phases. These data were obtained from the pooled spleen cells of three A/J
and five A/WySnJ mice. Original magnification of images was 25 .T
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Figure 7. Staining of GC B cells for Ki67, a nuclear proliferation marker. Spleen sections from days 6,
9, and 12 post-SRBC immunization were stained with anti-Ki67 (red) and GL7 (green). (A) GCs were
categorized into bright ( / ), moderately positive ( / ), and substantially reduced or undetectable ( / )
levels of Ki67 staining. (B) Ki67 expression in A/WySnJ and A/J control and BAFF /  and C57BL/6
GCs at different time points (C) Percentage of A/J and A/WySnJ GCs in each category. These data represent
35–50 randomly selected GCs from five mice from each group at each time point. Original magnification
of images was 25 . (D) The percentage of Ki67  cells in resting (0 h) and in in vitro anti-CD40 and IL-4–
stimulated (48 h) splenic B cells purified from A/J (hatched bar) and A/WySnJ (white bar) mice.T
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appears to play a critical and multifaceted role in GC pro-
gression.
Comparison of the data obtained from BAFF /  and
A/WySnJ mice strongly suggests a role for BAFF in the GC
response beyond stimulation of the BAFF-R on B cells.
Although large PNA  and GL7  splenic B cell clusters are
induced by SRBC immunization of BAFF /  mice, these
clusters lack the “mature” FDC reticulum characteristic of
GCs. Since FDCs have been suggested to play a central role
in the GC response (1, 42, 43), this defect may be at least
partially responsible for the failure of this response in
BAFF /  mice. Indeed, we found that FDCs in BAFF / 
GCs were deficient in the ability to trap and retain ICs.
Since the primary FDC reticulum appears normal in the
GCs of these mice, a flaw in the conversion of the primary
to the secondary FDC reticulum is suggested. Alternatively,
the cells that form the primary and secondary GC reticu-
lum could be distinct (29, 44), with the development of the
latter being critically dependent on BAFF. Fc RIIB-defi-
cient mice also display a defect in FDC maturation (29, 45).
Our observation that Fc RIIB fails to be induced on FDCs
in BAFF /  mice suggests that BAFF is required for early
steps in the FDC maturation pathway.
Given the central role played by B cell–derived lympho-
toxin (LT) in the development of follicles (51, 52), it
should also be considered that the primary defect in GC
progression results from insufficient B cell LT production
secondary to absence of BAFF stimulation. In an LT-defi-
cient environment, the mature FDC network may fail to
develop or be destabilized, precluding the provision of ge-
neric B cell growth and survival factors and downstream
steps necessary for GC progression, such as IC trapping,
antigen presentation to B cells, and B cell costimulation.
Indeed, previous studies showed that administration of
LT R-Ig or anti-LT  to mice with preexisting GCs re-
sulted in dissolution of the FDC network in those GCs
(53). Identification of the cellular source of BAFF that reg-
ulates GC development is an important goal for future in-
vestigation. Since normal lymphocytes are incapable of
producing this cytokine (9, 10), a GC myeloid or stromal
source of BAFF is implicated.
Although the lack of GC progression in BAFF /  mice
may be due to a GC accessory cell deficiency, this does not
appear to be the case in A/WySnJ mice. In these mice, a
cell autonomous defect in the capability of GC B cells to re-
ceive BAFF-derived signals appears to lead to their inability
to sustain the rapid cell cycle progression required to main-
tain the response. The expression of Ki67 in the GCs of
these BAFF-R–deficient mice is sporadic or undetectable at
later stages of the GC response, just before its rapid diminu-
tion, and is reduced even during the early stages of the re-
sponse. Ki67 expression was usually undetectable even in
medium-sized GCs during the near terminal stages of the
response, suggesting that premature GC B cell death was
not responsible. This notion was strengthened by our find-
ing that levels of intra-GC apoptosis were only slightly ele-
vated in A/WySnJ GCs (Fig. 5). This defect is not due to an
intrinsic inability of B cells to express Ki67, since primary
A/WySnJ B cells uniformly expressed high levels of Ki67
after in vitro stimulation with anti-CD40 and IL-4. This
raises the interesting possibility that the BAFF-R regulates
expression of intracellular factors essential for the sustenance
of normal GC B cell cycle progression, such as Ki67.
Since GC B cells in BAFF /  mice express normal levels
of Ki67, the perturbed Ki67 expression characteristic of
A/WySnJ GCs is most easily explained by a negative effect
on B cell proliferation due to partial function of the BAFF-R,
competing signaling by other previously or yet to be char-
acterized receptors for BAFF or both. Regarding the first
possibility, recent data suggest that multiple downstream
signaling pathways can be induced by BAFF-R engage-
ment (54, 55). The mutated form of the BAFF-R present
in A/WySnJ may transmit signals that inhibit rather than
promote GC B cell proliferation. Precedence for the idea
that single TNF-R family members are capable of both
Figure 8. Reduced Ki67 expression in A/WySnJ GCs is due to a B
cell autonomous defect. Spleen sections of A/J    MT → AB6F1 and
A/WySnJ    MT → AB6F1 chimeric mice from day 9 post-SRBC
immunization were stained with (A) anti-B220 (blue) and GK1.5-HRP
(red), (B) GL7-FITC (green) and FDC-M1 (red), (C) GL7-FITC
(green) and Ki 67 (red), and (D) GL7-FITC (green) and TCRC- -PE
(red). Original magnification of images was 10  in A and 25  in B–D.
The data represent one A/J    MT → AB6F1 and two A/WySnJ  
 MT → AB6F1 chimeras.T
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positive and negative signaling has been established recently
for CD40 (56). Regarding the influence of other BAFF re-
ceptors in the absence of normal BAFF-R function, since
TACI can mediate down-regulation of B cell activity (57,
58) it is tempting to speculate that when BAFF-R function
is compromised BAFF induces inhibition of cell cycle pro-
gression via TACI.
Yan et al. (15) previously found that in vivo treatment
of immunized mice with TACI-Fc abolished the develop-
ment of splenic GCs, leading to the conclusion that BAFF
is required for the GC response. This approach differs fun-
damentally from our study of mice genetically deficient in
BAFF or BAFF-R signaling. TACI-Fc would neutralize
not only BAFF, but also APRIL, and perhaps yet to be
identified TACI-specific ligands. Further, the degree to
which these cytokines are neutralized at their sites of ac-
tion by such fusion proteins is uncertain. Also, such Ig fu-
sion proteins could alter the activity or survival of cells
expressing membrane-bound forms of TNF cytokines.
Indeed, we conducted a preliminary examination of the
GC response to SRBC in mice treated with BCMA-Ig
and found the attenuation of the GC response was moder-
ate in comparison to BAFF /  mice (unpublished data).
Finally, the examination of GCs from TACI-Fc–treated
mice by Yan et al. (15) was performed at a single time
point, 14 d after immunization with Ag, leaving open the
possibility that GCs were induced early in the response
and then disappeared.
Certain TI antigens can induce transient GC formation
in normal or T cell–deficient mice (59, 60). Several factors
Table I. N Sequence Insertion at VH-D-JH Junctions of Rearranged J558 Family Genes from GC B Cells in A/J 
and A/WySnJ Mice
Clone # VH N/P D N/P JH
A/J
Ah1 AGA TGCTAT TATAGTAACTAC TAC
Ah2 AAG GGGAGGGTT CTA
Ah3 TGT ACCCCA AGTAACT CG GCC
Ah4 ACA GAGGGGTCT AACTGGGA AGGGGACTTCC GGG
Ah5 AGA GGCAAGGA CTACTATAGT GCC
Ah6 AGA GCAAGGA CTACTATAGT GCC
Ah7 AGA TCCCCCA TCTATGATGGTTACTAC AGT TTT
Ah8 AGA GACGG CTG
Ah9 AGA GGG TATAGTAACTAC GGTGT CTG
Ah10 AGA TCT AGACAGCTCGGGCT CCTAT ATT
Ah11 AGA TGCTAT TATAGTAACTAC TAC
A/WySnJ
Wh1 AGA GAGGAGGGCATTTAT TACTATGGTG GTG ACT
Wh2 GAA AATCCTTCTATAN TGACTAC GAT TGG
Wh3 AGA AAATCCTT CTATAGTGACTAC GAT TGG
Wh4 TGT ACCCATAGCCT TACTATAGTGACTAC GTTCGT TTT
Wh5 AGA TCCG GATGGTTA ACAC CCT
Wh6 CAA TACCCCCTT TATAGTAACTAC GG TTA
Wh7 AGA GGGTCCCCTGGTG GTAGCTAC T CCT
Wh8 AGA GGGTCCCCTGGTGA TAGCTAC T CCT
Wh9 AGA TGGGGACGGGG CTA
Wh10 AGA TGTAT TATAGTAACT GAC CTA
Wh11 ATA CCCCCTT TATAGTAACTAC GG TTA
Wh12 AGA GGAAAG ATTAATTACTATGGTGGTAGCTAC TAC
Wh13 AGA TGTAT TATAGTAACT GAC CTA
VHDJH junctions of rearranged Ig chain J558 family genes PCR amplified, cloned, and sequenced from GCs in SRBC immunized A/WySnJ and A/J
mice. PNA+ GC B cells were microdissected using a micromanipulator after the spleen sections were stained with PNA, and then J558 family gene
was amplified from the processed PNA+ GC B cells as described previously (34). Shown are three 3  nucleotides of the VH gene, the D element
(aligned with germline D elements from Ig BLAST), three 5  nucleotides of JH and N/P sequences at the VHD and DJH borders. Short sequence
homologies in DJH joints are shown in bold and are italicized. T
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and observations suggest that a T cell deficiency does not
contribute to the transitory nature of the GC response in-
duced in BAFF /  and A/WySnJ mice. First, T cell num-
bers and locale in the GC are normal in A/WySnJ and
BAFF /  mice (Fig. 3 C). Second, we observed no splenic
GC formation in completely T cell–deficient TCR C C 
knockout mice immunized with SRBC (unpublished data),
confirming that the response to SRBCs is completely TD.
Third, somatic hypermutation of antibody V region genes,
thought to be a TD process (38, 61), clearly occurs effi-
ciently in A/WySnJ GCs (Table II), and our studies using
prototypical TD antigens indicate that this process takes
place in the GCs of BAFF /  mice as well (62).
Another contributing factor to the premature termina-
tion of the GC response in BAFF /  and A/WySnJ mice
could be that the precursors of GC B cells in these mice are
intrinsically incapable of a sustained proliferative responses.
B cell development from the T1 to the T2 stage is severely
reduced in BAFF /  and A/WySnJ mice, yet B1 B cell de-
velopment appears unperturbed (19, 20, 25). In an envi-
ronment of reduced competition from mature B2 GC pre-
cursors, GCs might be nucleated by T1 or B1 B cells.
Although further studies will be required to adequately ad-
dress this issue, particularly in BAFF /  mice, our data on
N sequence diversity at VDJ junctions (Table I) suggest
that precursors of GC B cells in A/WySnJ are not B1 cells
(47, 48). V region somatic hypermutation takes place in
BAFF /  and A/WySnJ GCs, a capacity associated with
follicular B cells (1, 63). Finally, both A/WySnJ mice and
mice in which BAFF function is blocked can mount low
level, yet high affinity, class switched serum antibody re-
sponses to TD antigens (15, 18, 27), supporting the con-
clusion that follicular B cells are the main participants in
these responses.
In total, our data demonstrate that BAFF activity is cru-
cial for normal GC development and progression. By ex-
tension, these findings indicate that the BAFF–BAFF-R
pathway may be involved in the phenotypic selection of
GC B cells whose BCR specificities have been modified
via hypermutation. Finally, these data highlight the need
for investigating whether activity of the BAFF pathway is
also important for the development and maintenance of
late plasma and memory B cells, since these cells are de-
rived from the GC reaction.
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